
KORU Medical Systems posts 18.2% Q2 revenue growth but narrows full-year guidance amid slower international ramp.
KORU Medical Systems is evolving into a digitally enabled drug delivery platform, benefiting from growth in at-home subcutaneous infusion therapies. The company reported an 18.2% increase in Q2 revenue to $12.05 million, with improved net income and ...


